Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL). [PDF]
Ouerdani A+7 more
europepmc +1 more source
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia [PDF]
Aymerich, Marta+12 more
core +1 more source
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas. [PDF]
Chihara D+19 more
europepmc +1 more source
Predicting the risk of ibrutinib in combination with R-ICE in patients with relapsed or refractory DLBCL using explainable machine learning algorithms. [PDF]
Zhu N+11 more
europepmc +1 more source
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance) [PDF]
Fehniger, Todd A.
core +1 more source
Real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies. [PDF]
Karimi MA+10 more
europepmc +1 more source
Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia
Benjamin J. Arthurs+3 more
openalex +1 more source
Cardiotoxicity of small-molecule kinase inhibitors in cancer therapy. [PDF]
Zhu S+9 more
europepmc +1 more source
Ibrutinib-induced pyoderma gangrenosum
Andrzej Mital+5 more
openaire +3 more sources